'Signaling via TGFbeta receptors — possible targets in tumor treatment' - External lecture
Professor Carl-Henrik HELDIN is a world authority in molecular biology and cancer research.
His research focuses on the mechanisms of signal transduction by growth regulatory factors, as well as their normal function and role in disease. In particular, platelet-derived growth factor (PDGF), a major mitogen for connective tissue cells, and transforming growth factor β (TGFβ), which inhibits the growth of most cell types, are studied. The ultimate goal is to explore the possible clinical utility of signal transduction antagonists for the treatment of malignant diseases.
- Wednesday, November 20 at 17h, in the auditorium F on the UCL Health Sciences campus in Brussels & followed by a reception at the de Duve Institute.
- Registration before November 8 is mandatory.
- Website